Xconomy National

Archives

by in
Entry Author Date Location
Celgene Pours $15M Into Acetylon, Takes “Observer” Role on Board Arlene Weintraub 02/09/12 Boston
Brightcove, Radius, Synchroneuron, & More Boston-Area Dealmakers Erin Kutz 02/08/12 Boston
Radius Health Seeks $86M IPO Arlene Weintraub 02/07/12 Boston
Applied Proteomics, Co-Founded by Danny Hillis, Gets New CEO, $22.5M Bruce V. Bigelow 02/07/12 San Diego
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy Bruce V. Bigelow 02/03/12 San Diego
Dendreon Names John Johnson CEO After Volatile Year Arlene Weintraub 02/01/12 Seattle
AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics Luke Timmerman 02/01/12 San Francisco
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says Luke Timmerman 02/01/12 Boston
Avila, iRobot, Verastem, Illume, & More Boston Deal News Erin Kutz 02/01/12 Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug Luke Timmerman 01/31/12 Boston
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic Luke Timmerman 01/31/12 San Diego
Four Themes to Watch in Personalized Medicine Jonathan Sheffi 01/30/12 San Francisco
Gates, 13 Pharmas Join $785M Push for Neglected Diseases Luke Timmerman 01/30/12 Seattle
FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis Arlene Weintraub 01/30/12 Boston
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel Luke Timmerman 01/30/12 Seattle
Never Back Smug: A Lesson for Life Sciences From Newt Gingrich Luke Timmerman 01/30/12 National
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug Luke Timmerman 01/27/12 National
Infinity Drug Fails in Pancreatic Cancer Trial, Shares Fall Luke Timmerman 01/27/12 Boston
2012 Venture Outlook: Some Bright Spots and Some Gloom Bruce V. Bigelow 01/27/12 National
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation Luke Timmerman 01/27/12 Seattle
Why Biogen Idec Got Out of the Corporate VC Business Luke Timmerman 01/27/12 Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers Erin Kutz 01/27/12 Boston
Verastem Bucks the Trend, Raises $55M in IPO Luke Timmerman 01/26/12 Boston
Shout Outs for Avila From Polaris, Atlas, & the Twittersphere Luke Timmerman 01/26/12 Boston
New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event Arlene Weintraub 01/26/12 Boston
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs Arlene Weintraub 01/26/12 Boston
Theraclone, VLST Founders Form New Antibody Startup, V-Gene Luke Timmerman 01/26/12 Seattle
Roche Makes $5.7B Hostile Takeover Bid for Illumina Luke Timmerman 01/25/12 San Diego
Family Affair: Courtagen Applies Management DNA to Genomics Startup Arlene Weintraub 01/25/12 Boston
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly Luke Timmerman 01/25/12 San Francisco
Page 1 of 159 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.